健帆生物(300529.SZ)解聘原2019年度會計師事務所瑞華
格隆匯11月3日丨健帆生物(300529.SZ)公佈,公司於2019年11月1日召開的第三屆董事會第三十九次會議及第三屆監事會第三十次會議審議通過了《關於變更審計機構的議案》,同意公司解聘原2019年度會計師事務所瑞華,並聘請致同為公司2019年度審計機構、負責公司2019年度財務報表審計工作及內部控制審計工作。
公司原審計機構瑞華會計師事務所(特殊普通合夥)(“瑞華”)在執業過程中堅持獨立審計原則,客觀、公正、公允地反映公司財務狀況,切實履行了審計機構應盡的職責,從專業角度維護了公司及其股東的合法權益。因瑞華審計團隊已經連續多年為公司提供審計服務,為確保上市公司審計工作的獨立性與客觀性,同時更好地適應公司未來業務發展需要,經與瑞華會計師事務所(特殊普通合夥)友好溝通,確定不再續聘其承擔年度審計工作。公司對其以來在公司審計工作中表現出來的專業、盡責的工作精神表示誠摯的感謝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.